Bioxytran Inc (BIXT)

[PStockPickz]

Some churning here looking good

[Zardiw]

$BIXT has a Drug that cures Covid/Viruses......100% Drug Trial positive results in that 8K and PR ............

Z

[PStockPickz]

Nice slaps coming in. Lot of upside

[PStockPickz]

We got a gapper

[i_like_bb_stock]

nice news https://www.otcmarkets.com/stock/BIXT/news/Bioxytran-Releases-Positive-Top-line-Results-from-Phase-2-Trial-of-Galectin-Antagonist-on-COVID-19-Patients-in-medRxiv-P?id=380469

[govprs]

Can’t believe this isn’t exploding in pre market. No one is paying attention

[misiu143]

IMO only , BP is a VERY big problem !!!!

[PStockPickz]

Nice news out this morning!

[harthay]

$BIXT AMAZING NEWS

Let’s goooooooo!!!!

https://finance.yahoo.com/news/bioxytran-releases-positive-top-line-120000424.html

Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print
Complete elimination of viral load in 100% of patients at day 7 vs 6% in placebo (p=.001)

Complete elimination of viral load in 88% of patients at day 3 vs 0% in placebo (p=.001)

Treated population experienced no viral rebounds within the 14-day observation period

BOSTON, Nov. 16, 2022 /PRNewswire/ -- BIOXYTRAN, INC. (OTCQB: BIXT), (the "Company"), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral diseases, announced positive topline safety and efficacy results of its randomized, placebo-controlled Phase 2 clinical trial in 34 patients with mild-to-moderate COVID-19. During the 7 days of treatment, an orally administered Galectin Antagonist in the form of a chewable tablet was administered 8 times per day on an hourly basis. The endpoint was a statistically significant reduction in viral load measured by the number of patients reaching a below threshold PCR value (Ct value ≥ 29) by day 7. The trial met its endpoint with a 100% response rate by day 7 versus 6% in placebo, which was statistically significant (p-value = .001). Our analysis also revealed an 88% response rate by day 3, which was statistically significant (p-value = .001). There were no drug-related serious adverse events (SAE's) in the patient population or viral rebounds by day 14 in the patient population. The positive data from this clinical trial provided the rationale of dosing and protocol design for study in an upcoming phase 2/3 registrational trial.

The full text of the preprint is located at the following link.
https://www.medrxiv.org/content/10.1101/2022.11.09.22282151v1

[Zardiw]

If $BIXT can cure all viruses.......they're gonna get major resistance from Big Pharma......which doesn't WANT to cure diseases.....they just want to make money medicating them........Sort of like renting a house to us, instead of selling it to us.

Z

[Retire43]

This is great news!

[Zardiw]

Sounds pretty outstanding.......... $BIXT could change the entire world for the better.......

Z

[misiu143]

Yes , I am reading and researching this drug , and so far I am impressed ..
3 Days on the drug and no more virus detected in Covid ..
Still early study but look good imo...

[Ecomike]

That is exactly what they have...

"I'm thinking there could be Other viruses the $BIXT drug would work on........Like the Flu........and even the Common Cold.....now THAT would be insane.......lol "

Rvvtf bucillamine also can help, but not as fast (used safely in Japan and So Korea for 33 years now for Autoimmune RA. It regenerates Glutathione and liquidates micro blood clots, blocking blood flow in capillaries that weeks old brand new science, etc, research data shows is the COMMON CAUSE of all auto-immune diseases and possibly Alzheimers as they connected the dots there too...
Used together IMO, the world would have a gang banger fix combo for flu-cold-corona-covid viruses and likely stop further damage from Long haul covid.

[Retire43]

There are numerous viruses that this drug or a modification of this drug might be successful with treatments or cures!

[Retire43]

https://o.b5z.net/i/u/10253529/f/BIXT_Article.pdf

[Zardiw]

I'm thinking there could be Other viruses the $BIXT drug would work on........Like the Flu........and even the Common Cold.....now THAT would be insane.......lol

Z

[Ecomike]

The trials in India show that their galectin product stops the ability of the virus to infect cells and thus eliminates all signs of Covid19 in 3 days, in early trials.

Still needs to do the phase III Human trials. Looks like they will focus on reduced transmission instead of reduced deaths and reduced hospital ICU cases as the latest versions of Covid19 are now a transmission stopping issue, and not so much a mass death issue. It is also a long haul health issue, so it would be interesting to see it tested on those cases...

Rvvtf, one that is close to the end of an FDA covid19 EUA trial repurposing an RA drug started their trials on mild cases and reduced hospitalizations for Wuhan Covid and Covid-D, , but they are now trying to change the end points to match the reality of the new strains, Omicron.... and targeting faster end of symptoms....

I own shares in both. In fact, I think both could be used together, dealing with 2 separate parts of the covid problems. Long story for another post someday...

[Zardiw]

They're saying that $BIXT has a drug that prevents Covid Transmission.......now THAT is pretty amazing.......:

https://www.medrxiv.org/content/10.1101/2022.11.09.22282151v1

Abstract

Background SARS-CoV-2 vaccines play an important role in reducing disease severity, hospitalization, and death, although they failed to prevent the transmission of SARS-CoV-2 variants. Therefore, an effective antiviral such as a Galectin-3 (Gal-3) antagonist might have the potential to prevent viral transmission. ProLectin-M (PL-M), a Gal-3 antagonist, has been shown to have anti-SARS-CoV-2 activity in previous studies.

Aim The present study aimed to further evaluate the antiviral effect of PL-M tablets in 34 subjects with COVID-19 disease, in addition to determining the antiviral mechanisms of PL-M by NMR studies.

Methods The efficacy of PL-M was evaluated in a randomized, double-blind, placebo-controlled clinical study in patients with mild to moderately severe COVID-19. Primary endpoints included changes in absolute RT-PCR Ct values of the nucleocapsid and open reading frame (ORF) genes from baseline to days 3 and 7. The incidence of adverse events, changes in blood biochemistry, inflammatory biomarkers, and levels of antibodies against COVID-19 were also evaluated as part of the safety evaluation. In vitro 1H-15N HSQC NMR spectroscopy studies were also performed to determine the interactions of PL-M with Gal-3 and the S1 spike protein of SARS-CoV-2.

Results PL-M treatment significantly (p = 0.001) increased RT-PCR cycle counts for N and ORF genes on days 3 (Ct values 32.09 and 30.69 +/-3.38, respectively) and 7 (Ct values 34.91 +/-0.39 and 34.85 +/-0.61, respectively) compared to placebo. All subjects were RT-PCR negative for both genes in the PL-M treatment group from day 3 onwards. The Ct values in the placebo group were consistently less than 29 (target cycle count 29) for both genes until day 7, and no placebo subjects were negative by RT-PCR. 1H-15N HSQC NMR spectroscopy revealed that PL-M specifically binds Gal-3 in the same way as the structurally similar NTD of the SARS-CoV-2 S1 subunit.

Conclusion PL-M is safe and effective for clinical use in reducing viral load and promoting rapid viral clearance in COVID-19 patients by inhibiting SARS-CoV-2 entry into cells through inhibition of Gal-3.

Competing Interest Statement

Competing interest reported. All the authors have received funding from Pharmalectin, a unit of Bioxytran Inc. Pharmalectin has copyrights to the molecule and Murlikrishna Pharmaceuticals have taken a contract to manufacture the product. The corresponding author receives a consultation fee from Pharmalectin.
Clinical Trial

CTRI/2022/03/040757
Funding Statement

This study was funded by Pharmalectin, a unit of Bioxytran Inc.
Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Z

[Ecomike]

It is a game changer new drug stock. It is trading at a rock solid floor wall at .40 and whales are stealth eating the floor zone here. The technology they have is an antiviral game changer technology. This I have verified...
Could run any day or week.

It is a Biotech/Drug firm with the right people running it...

This is great price range .40 to .50 to load heavy, before 10 bagger news goes poof.

No clue if that is this month or early next year.... I am in for the long haul with core shares...

[misiu143]

Good read...
https://www.medrxiv.org/content/10.1101/2022.11.09.22282151v1

[Zardiw]

Is this a good stock?

Z

[Retire43]

Yes! When you look at the website and see there is not just one drug or one device in the pipeline! There are many! So much potential in this company with an amazing proven CEO at the helm!

[govprs]

Nice action today. A run coming???

[Ecomike]

Looks like solid bottom to add more shares here folks. Time to get greedy $BIXT

There is a whole lot more here under the hood the more I DD the science here

[Retire43]

This is a new science that will fight viral infection Glycovirology!

[De302]

https://www.benzinga.com/pressreleases/22/10/g29392723/bioxytran-scientific-advisor-releases-new-book-on-brain-metabolism

[Ecomike]

Where? Link to the new book?

I heard there was news a day ago, where is it?

[De302]

Bioxytran Scientific Advisor Releases New Book on Brain Metabolism

[Retire43]

New news out this morning!

[i_like_bb_stock]

nice day

[Ecomike]

$BIXT up 17.6% today, when most other Bio-drug tech stocks were red...

Bottom / dip support test looks done. News must coming soon IMO...

Covid19 off spring, 2 new ones are taking off already was cold weather arrives...

[i_like_bb_stock]

1/2 the price

[Ecomike]

We need a chart to see if there is a back test, MA test underway, and what those prices are here.

[Ecomike]

Low volume gifts here at 2/3 off the recent highs, on a green A-Z day is a screaming buy.

[i_like_bb_stock]

got some here in the 40s was over a dollar not long ago

[RMacchio]

When did we get back the OTC-QB back on $BIXT?

Didn't BIXT used to be an OTC-PK stock? The OTCMarkets.com website shows that BIXT started on the OTC-QB in Sep 2022, so it must have just been upgraded.

[Ecomike]

Indeed.

https://www.science.org/content/article/big-covid-19-waves-may-be-coming-new-omicron-strains-suggest

When did we get back the OTC-QB back on $BIXT?

I thought that had already happened? Maybe it just been applied for, I forget...

[Retire43]

https://www.science.org/content/article/big-covid-19-waves-may-be-coming-new-omicron-strains-suggest

This is going to get ugly!

World needs ProLectin

[Retire43]

Totally agree!

[Retire43]

BIXT has regained its otcQB status!

[i_like_bb_stock]

Agreed

[Ecomike]

99.999999999999% of the market has no clue yet how huge the next gen, 100% non toxic Galectin antiviral chemistry $BIXT is bringing to market, is....

If Pfizer or Novartis,.... was smart they would make a deal to accelerate this with a JV...

That kind of news always arrives with no warning...

[Retire43]

Yes. Looked into this
Polio!
BIXT’s ProLectin needs testing !

[Ecomike]

$BIXT SEC filling news, S-1 withdrawal and no shares issued...

https://ih.advfn.com/stock-market/USOTC/bioxytran-pk-BIXT/stock-news/89121937/withdrawal-of-a-registration-statement-withdrawal

Sounds like very positive news to me...

[$theDDmessiah]

$BIXT did its thing gave to my peeps ;)

[$theDDmessiah]

BRL* about to go to dollars next

[Ecomike]

Twitter is on fire today talking about $BIXT, lots of new eyes on this one.

BBL...

[Ecomike]

I heard this morning the CDC warned about a new Polio like virus, brand new virus that is loose. Paralysis like Polio..

Thanks, I shared it to about 800 folks already. Going to Reddit and Twitter now

[Ecomike]

I know about 6 of them whales....



The real whaling looks like it started today